Enpicom ImmunoGenomix Platform

Dutch bioinformatics software engineering company Enpicom has released the first version of its ImmunoGenomix platform to support the development of immunotherapies, as well as patient stratification and treatment monitoring. The firm will expand the platform into a comprehensive immunosequencing data analysis platform designed to analyze, monitor, and compare the immune repertoires in the context of immunotherapy development and at all stages of treatment and disease over time. The platform will enable customers to use their own sample preparation protocols and preferred next-generation sequencing technology.